Clinical Trials
3 trialsNCT05062889 2026-02-03
ERASE-CRC
Gruppo Oncologico del Nord-Ovest
Phase 2 Suspended
NCT04120246 2024-07-10
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer
Veana Therapeutics
Phase 1 Suspended
NCT02062983 2016-05-13
Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients
National Guard Health Affairs
Suspended